You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

PREMPRO (PREMARIN;CYCRIN) Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Prempro (premarin;cycrin), and when can generic versions of Prempro (premarin;cycrin) launch?

Prempro (premarin;cycrin) is a drug marketed by Wyeth Pharms Inc and is included in one NDA.

The generic ingredient in PREMPRO (PREMARIN;CYCRIN) is estrogens, conjugated; medroxyprogesterone acetate. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estrogens, conjugated; medroxyprogesterone acetate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PREMPRO (PREMARIN;CYCRIN)?
  • What are the global sales for PREMPRO (PREMARIN;CYCRIN)?
  • What is Average Wholesale Price for PREMPRO (PREMARIN;CYCRIN)?
Summary for PREMPRO (PREMARIN;CYCRIN)
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 72
DailyMed Link:PREMPRO (PREMARIN;CYCRIN) at DailyMed
Drug patent expirations by year for PREMPRO (PREMARIN;CYCRIN)

US Patents and Regulatory Information for PREMPRO (PREMARIN;CYCRIN)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms Inc PREMPRO (PREMARIN;CYCRIN) estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020303-001 Dec 30, 1994 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PREMPRO (PREMARIN;CYCRIN)

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc PREMPRO (PREMARIN;CYCRIN) estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020303-001 Dec 30, 1994 ⤷  Sign Up ⤷  Sign Up
Wyeth Pharms Inc PREMPRO (PREMARIN;CYCRIN) estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020303-001 Dec 30, 1994 ⤷  Sign Up ⤷  Sign Up
Wyeth Pharms Inc PREMPRO (PREMARIN;CYCRIN) estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020303-001 Dec 30, 1994 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PREMPRO (PREMARIN;CYCRIN)

See the table below for patents covering PREMPRO (PREMARIN;CYCRIN) around the world.

Country Patent Number Title Estimated Expiration
Japan H07504197 ⤷  Sign Up
Luxembourg 91096 ⤷  Sign Up
Netherlands 300033 ⤷  Sign Up
Netherlands 970037 ⤷  Sign Up
Austria 174342 ⤷  Sign Up
Hong Kong 1011369 ⤷  Sign Up
Germany 10199010 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for PREMPRO (PREMARIN;CYCRIN)

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0136011 2000C/027 Belgium ⤷  Sign Up PRODUCT NAME: ETHINYLESTRADIOLUM / NORETHISTERONI ACETAS; NAT. REGISTRATION NO/DATE: 19 IS 106 F3 20000911; FIRST REGISTRATION: NL RVG 23909 19991124
0136011 99C0003 Belgium ⤷  Sign Up PRODUCT NAME: ESTRADIOL AND NORETHISTERONE; FIRST REGISTRATION NO/DATE: 403 IS 106 F3 19980928; FIRST REGISTRATION: SE 14007 19980306
0136011 980038 Netherlands ⤷  Sign Up 980038, 20090801, EXPIRES: 20130305
0136011 SPC/GB00/025 United Kingdom ⤷  Sign Up SPC/GB00/025: 20040802, EXPIRES: 20090801
0136011 SPC/GB00/028 United Kingdom ⤷  Sign Up SPC/GB00/028: 20040802, EXPIRES: 20090801
0136011 91096 Luxembourg ⤷  Sign Up 91096, EXPIRES: 20090802
0136011 SPC/GB02/008 United Kingdom ⤷  Sign Up SPC/GB02/008: 20040802, EXPIRES: 20090801
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.